{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: These complications have included clinical deterioration and intracranial vascular thrombosis in patients with SAH , arteriolar and capillary fibrin thrombi in patients with fibrinolytic syndromes treated with EACA , or other thromboembolic phenomena .\n\nLet's think step by step."},
    {"role": "assistant", "content": "Sure! Here are the \"Disease\" entities in the paragraph you provided:\n\n| Disease |\n| --- |\n| Subarachnoid hemorrhage (SAH) |\n| Fibrinolytic syndromes |\n| Intracranial vascular thrombosis |\n| Arteriolar and capillary fibrin thrombi |\n| Thromboembolic phenomena |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Sure, here are the valid entities that clearly refer to \"Disease\" in the paragraph you provided, presented as a Markdown table with one column \"Disease\":\n\n| Disease |\n| --- |\n| Subarachnoid hemorrhage (SAH) |\n| Fibrinolytic syndromes |\n| Intracranial vascular thrombosis |\n\nI removed \"Arteriolar and capillary fibrin thrombi\" and \"Thromboembolic phenomena\" from the list as they are not clearly referring to diseases, but rather to symptoms or complications related to the diseases mentioned."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: These complications have included clinical deterioration and intracranial vascular thrombosis in patients with SAH , arteriolar and capillary fibrin thrombi in patients with fibrinolytic syndromes treated with EACA , or other thromboembolic phenomena .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| SAH |\n| EACA |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Sure, here are the valid entities that clearly refer to \"Chemical\" in the given paragraph, presented as a Markdown table with one column \"Chemical\":\n\n| Chemical |\n| --- |\n| EACA |\n\nThe entity \"SAH\" does not clearly refer to a chemical entity, and therefore has been removed from the list."}
  ]
}